Literature DB >> 25527410

Susceptibility to gastric cancer and polymorphisms of insertion/deletion at the intron 3 of the XRCC4 and VNTR at the promoter region of the XRCC5.

Mostafa Saadat1, Samira Pashaei, Foroozan Amerizade.   

Abstract

The genes encoding X-ray repair cross-complementing group 4 (XRCC4; OMIM: 194363) and 5 (XRCC5; OMIM: 194364) are involved in repair of DNA double-strand breaks. To investigating the associations between polymorphisms of Insertion/Deletion (I/D, rs28360071) in the intron 3 of the XRCC4 and VNTR in the promoter region of the XRCC5 and risk of gastric cancer, the present study was carried out. We included 159 (56 females, 103 males) with gastric cancer and 242 (75 females, 167 males) healthy blood donors frequency matched for age and gender. Using PCR-based methods, the genotypes of the study polymorphisms were determined. The alleles of VNTR XRCC5 polymorphism divided into two groups: L (0 and 1 repeats) and H (2 and 3 repeats) alleles. For the I/D XRCC4 polymorphism, after stratification of the subjects according to their family history (FH) of cancer, either the ID (OR = 3.19, 95%CI: 1.35-7.50, P = 0.008) or the DD genotypes (OR = 4.62, 95%CI: 1.63-13.0, P = 0.004) among positive FH persons, increased the risk of gastric cancer compared with the reference group (persons who have negative FH and II genotype). For the VNTR XRCC5 polymorphism, the LH + HH genotypes among positive FH persons, increased the risk of gastric cancer compared with the reference group (persons who have negative FH and LL genotype) (OR = 2.88, 95%CI: 1.34-6.18, P = 0.006). Sensitivity analysis showed that the above mentioned associations were not occurred due to the maldistribution of the genotypes among missing data. The present study suggests that both polymorphisms of the XRCC4 and XRCC5 might be risk factors for gastric cancer development especially among persons with positive FH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527410     DOI: 10.1007/s12253-014-9875-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

1.  Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.

Authors:  Kang-Hsi Wu; Chung-Hsing Wang; Yung-Li Yang; Ching-Tien Peng; Wei-De Lin; Fuu-Jen Tsai; Dong-Tsamn Lin; Da-Tian Bau
Journal:  Anticancer Res       Date:  2010-02       Impact factor: 2.480

2.  Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.

Authors:  Rui Li; Yuan Yang; Yu An; Yun Zhou; Yanhong Liu; Qing Yu; Daru Lu; Hongyang Wang; Li Jin; Weiping Zhou; Ji Qian; Yin Yao Shugart
Journal:  Carcinogenesis       Date:  2011-02-08       Impact factor: 4.944

3.  Introducing a novel allele for the polymorphism of variable number of tandem repeats in the promoter region of XRCC5.

Authors:  Mehrdad Rajaei; Iraj Saadat; Mostafa Saadat
Journal:  Biochem Biophys Res Commun       Date:  2012-09-26       Impact factor: 3.575

4.  Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development.

Authors:  Y Gao; D O Ferguson; W Xie; J P Manis; J Sekiguchi; K M Frank; J Chaudhuri; J Horner; R A DePinho; F W Alt
Journal:  Nature       Date:  2000-04-20       Impact factor: 49.962

5.  Epidemiologic research on the genetic risk factors in gastric and colorectal cancer.

Authors:  T Drăghicescu; I C Roman; L Păltănea
Journal:  Rom J Morphol Embryol       Date:  1998 Jan-Dec       Impact factor: 1.033

6.  DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.

Authors:  M J Difilippantonio; J Zhu; H T Chen; E Meffre; M C Nussenzweig; E E Max; T Ried; A Nussenzweig
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

7.  Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran).

Authors:  Parisa Mohamadynejad; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2007-09-14       Impact factor: 2.316

8.  A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.

Authors:  Y Gao; Y Sun; K M Frank; P Dikkes; Y Fujiwara; K J Seidl; J M Sekiguchi; G A Rathbun; W Swat; J Wang; R T Bronson; B A Malynn; M Bryans; C Zhu; J Chaudhuri; L Davidson; R Ferrini; T Stamato; S H Orkin; M E Greenberg; F W Alt
Journal:  Cell       Date:  1998-12-23       Impact factor: 41.582

9.  Association of XRCC5 VNTR polymorphism with the development of chronic myeloid leukemia.

Authors:  Manjula Gorre; Prajitha Edathara Mohandas; Sailaja Kagita; Sandhya Annamaneni; Raghunadharao Digumarti; Vishnupriya Satti
Journal:  Tumour Biol       Date:  2013-08-28

10.  Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck.

Authors:  Hyo Won Chang; Sang Yoon Kim; So-Lyoung Yi; Se-Hee Son; Do Young Song; Su Young Moon; Jong Hoon Kim; Eun Kyung Choi; Seung Do Ahn; Seong Soo Shin; Kang Kyoo Lee; Sang-Wook Lee
Journal:  Oral Oncol       Date:  2006-02-03       Impact factor: 5.337

View more
  1 in total

1.  Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers.

Authors:  Jian Cui; Jiangtao Luo; Yeong C Kim; Carrie Snyder; Dina Becirovic; Bradley Downs; Henry Lynch; San Ming Wang
Journal:  Front Oncol       Date:  2016-04-13       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.